CEACAM5 and neoplasm: Overall, the synergistic evaluations indicated that for high CEA-expressing tumor models, such as the SNU1544 and HT55, combining 177Lu-DOTA-M5A and onalespib eventually lead to synergistic therapeutic effects in some combinations regarding both spheroid size ratio and viability at the end of the experiments.